Roche Creates PCR Tests That Can Single Out Omicron Variant
This article is for subscribers only.
Swiss drugmaker Roche Holding AG has developed PCR tests that can single out infections with the omicron variant of Covid-19, which would help countries monitor the spread of the new strain.
Roche said Friday its recently acquired TIB Molbiol unit is introducing three such tests for research use only.